HYPERION DEFI, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
HYPERION DEFI, INC. (HYPD) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $2.71 per share for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2021-03-30
- HYPERION DEFI, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2020-09-30 was $2.71, a 12.86% decline year-over-year.
- HYPERION DEFI, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2020-06-30 was $2.13.
- HYPERION DEFI, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2020-03-31 was $4.13, a 65.20% increase year-over-year.
- HYPERION DEFI, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2019-09-30 was $3.11.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 0 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month as first filed |
|---|---|---|---|---|---|---|
| 2020-09-30 | $2.71 10-Q · filed 2020-11-12 | $2.24 10-Q · filed 2020-11-12 | ||||
| 2020-06-30 | $2.13 10-Q · filed 2020-08-14 | $2.17 10-Q · filed 2020-08-14 | ||||
| 2020-03-31 | $4.13 10-Q · filed 2020-05-14 | |||||
| 2019-09-30 | $3.11 10-Q · filed 2020-11-12 | $3.10 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | $2.50 10-Q · filed 2020-08-14 | |||||
| 2019-05-14 | $1.95 10-Q · filed 2019-11-13 | $1.95 10-K · filed 2021-03-30 | ||||
| 2019-03-31 | $2.50 10-Q · filed 2020-05-14 | |||||
| 2019-02-06 | $1.24 10-K · filed 2021-03-30 | |||||
| 2019-01-02 | $1.24 10-K · filed 2021-03-30 | |||||
| 2018-09-30 | $6.39 10-Q · filed 2019-11-13 | $1.95 10-Q · filed 2018-11-13 | ||||
| 2018-06-30 | $8.72 10-Q · filed 2019-08-13 | $8.72 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |